Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2021)

First Author: RECOVERY Collaborative Group
Attributed to:  Wellcome Trust MRC Human Inducible Pluripotent Stem Cell Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.70428

Publication URI: https://www.repository.cam.ac.uk/handle/1810/322973

Type: Journal Article/Review